Avantor and Amgen receive Edison Award for biotech innovation

Avantor, Inc., a global leader in mission-critical products and services for the life sciences and advanced technology sectors, announced that it has jointly received the 2025 Edison Patent Award with Amgen from the Research & Development Council of New Jersey. The award recognizes their breakthrough creation of a biodegradable detergent designed to make viral inactivation in biomanufacturing safer and more environmentally sustainable.Developed collaboratively by Avantor and Amgen, the innovative detergent achieves effective viral inactivation while preserving protein quality and improving overall process efficiency. This advancement addresses a major challenge in the bioprocessing industry by offering a compliant, high-performance, and eco-friendly alternative for manufacturing monoclonal antibodies, vaccines, and gene therapies.“We are proud to be acknowledged by the R&D Council of New Jersey for this milestone,” said Benoit Gourdier, executive vice president of bioscience production at Avantor. “This partnership highlights how collaborative innovation can elevate scientific progress and environmental stewardship in biomanufacturing. By creating safer and more sustainable detergents, Avantor is helping customers produce essential therapies responsibly and with reduced ecological impact.”The technology was developed at Avantor’s Bridgewater Innovation Center, further solidifying the company’s leadership in sustainable bioprocessing and demonstrating the value of industry collaboration. The achievement also underscores New Jersey’s growing reputation as a global center for scientific innovation and sustainable technology. Avantor continues to be a prominent provider of life science tools and essential products and services for organizations operating in the life sciences and advanced technology fields.